The Human Tissue (Authorisation) (Specified Type A Procedures) (Scotland) Regulations 2020

Made: 12th March 2020

Coming into force in accordance with regulation 1

The Scottish Ministers make the following Regulations in exercise of the powers conferred by sections 16B(1) and (2) of the Human Tissue (Scotland) Act 2006 and all other powers enabling them to do so.

In accordance with section 16B(4) of that Act they have consulted with such persons as they consider appropriate.

In accordance with section 59(3)(ad) of that Act, a draft of this instrument has been laid before and approved by resolution of the Scottish Parliament.

Citation and commencement

1

These Regulations may be cited as the Human Tissue (Authorisation) (Specified Type A Procedures) (Scotland) Regulations 2020 and come into force on the day on which section 23 of the Human Tissue (Authorisation) (Scotland) Act 2019 comes into force for all purposes.

Type A procedures

2

The pre-death procedures specified in the second column of the table in the schedule are specified as Type A procedures for the purposes of sections 16D to 16F of the Human Tissue (Scotland) Act 2006 .

SCHEDULE — Specification of Pre-Death Procedures

1

In this schedule—

• “arterial line” means a cannula inserted into an artery,

• “blood component” means any of the following constituents of human blood—red cells,white cells,platelets, andplasma,

• “blood product” means any therapeutic product derived from human blood or plasma,

• “intravenous fluids” means any electrolyte solution intended for intravenous administration,

• “pre-established airway and ventilatory support” means any method of airway or ventilatory support administered to the person for the primary purpose of the person's medical treatment prior to any decision to withdraw life sustaining treatment,

• “pre-established suprapubic catheter” means a suprapubic catheter inserted into the person for the primary purpose of the person's medical treatment prior to any decision to withdraw life sustaining treatment.Class of procedureType of procedureCollection of bodily fluids and microbiological samplesTaking of a blood sampleTaking of a urine sample including by way of a pre-established suprapubic catheterTaking of a chest secretion sample (excluding bronchoscopy)Swabbing or scraping of the body including inside of the mouth, nostril or ear canal but excluding the swabbing or scraping of any part of any other body orificeRadiological imagingCarrying out of an X-Ray without transferring the person from their existing locationCarrying out of ultrasound imaging without transferring the person from their existing locationCarrying out of transthoracic echocardiography without transferring the person from their existing locationCardiovascular monitoringCarrying out of electrocardiogramCardiac output monitoring by way of an arterial lineCarrying out of central venous pressure monitoringArterial blood pressure monitoring including by way of an arterial lineRespiratory monitoring and supportMeasuring of oxygen saturationSustaining the appropriate operation of any pre-established airway and ventilatory supportAdministration of medication or other productAdministration of antimicrobialsAdministration of intravenous fluidsAdministration of medication to manage blood pressureAdministration of blood, blood components and blood products

Signed

JOE FITZPATRICK — Authorised to sign by the Scottish Ministers — 2020-03-12

Explanatory note

(This note is not part of the Regulations)

Footnotes

[^f00001]: 2006 asp. 4. Section 16B was inserted by section 23(1) of the Human Tissue (Authorisation) (Scotland) Act 2019 asp 11 (“the 2019 Act”).

[^f00002]: Section 59(3)(ad) was inserted by 23(2) of the 2019 Act.

[^f00003]: 2019 asp 11.

[^f00004]: Sections 16D to 16F were inserted by section 23(1) of the 2019 Act.

Editorial notes

[^c23990431]: 2006 asp. 4. Section 16B was inserted by section 23(1) of the Human Tissue (Authorisation) (Scotland) Act 2019 asp 11 (“the 2019 Act”).

[^c23990441]: Section 59(3)(ad) was inserted by 23(2) of the 2019 Act.

[^c23990451]: 2019 asp 11.

[^c23990461]: Sections 16D to 16F were inserted by section 23(1) of the 2019 Act.

[^key-c283300c133b189e12572d24e3c30e8f]: Reg. 1 in force at 26.3.2021, see reg. 1; S.S.I. 2021/108, reg. 2

[^key-96eae64ff66c040c8839a882c36f6000]: Reg. 2 in force at 26.3.2021, see reg. 1; S.S.I. 2021/108, reg. 2

[^key-eead11b3836ab7f9a1c8f4c7895020f9]: Sch. para. 1 in force at 26.3.2021, see reg. 1; S.S.I. 2021/108, reg. 2